Age-related differences in rabbits during experimental Staphylococcus aureus keratitis

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 11, 2007, Pages 5125-5131

  O'Callaghan, Richard J ^a,b   McCormick, Clare C ^a,b   Caballero, Armando R ^a,b   Marquart, Mary E ^a,b   Gatlin, Hattie P ^a   Fratkin, Jonathan D ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; HEMOLYSIN; PEROXIDASE; STAPHYLOCOCCAL ALPHA-TOXIN; STAPHYLOCOCCUS ALPHA TOXIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BIOASSAY; CONTROLLED STUDY; CORNEA; DISEASE PREDISPOSITION; ERYTHROCYTE; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; GROUPS BY AGE; HEATING; HEMOLYSIS; HISTOPATHOLOGY; INFECTION SENSITIVITY; KERATITIS; NEUTROPHIL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PURIFICATION; SCORING SYSTEM; SLIT LAMP; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; ANIMAL; BACTERIAL EYE INFECTION; CORNEA STROMA; CORNEA ULCER; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; INJECTION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; RABBIT; STAPHYLOCOCCUS INFECTION; VIRULENCE;

AGING; ANIMALS; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CORNEAL STROMA; CORNEAL ULCER; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EYE INFECTIONS, BACTERIAL; HEMOLYSIN PROTEINS; INJECTIONS; NEUTROPHILS; PEROXIDASE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 38449107986     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0320     Document Type: Article

References (55)

1. Foster TJ. The Staphylococcus aureus "superbug." J Clin Invest. 2004;114:1693-1696.
2. Hsueh PR, Teng LJ, Chen WH, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother. 2004;48:1361-1364.
3. Willens HJ, Kramer HJ, Vuoto T, Morris S. Images in geriatric cardiology - Staphylococcus aureus mitral valve endocarditis. Am J Geriatr Cardiol. 1999;8:307-308.
4. Akova YA, Onat M, Koc F, Nurozler A, Duman S. Microbial keratitis following penetrating keratoplasty. Ophthalmic Surg Lasers. 1999;30:449-455.
5. Aquino VM, Pappo A, Buchanan GR, Tkaczewski I, Mustafa MM. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J. 1995;14:140-143.
6. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834-838.
7. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet. 1991;338:650-653.
8. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med. 1999;27:1421-1428.
9. Grundmann H, Tami A, Hori S, Halwani M, Slack R. Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. Br Med J. 2002;324:1365-1366.
10. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109-116.
11. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106:1166-1171.
12. Arkwright PD, Daniel TO, Sanyal D, David TJ, Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol. 2002;138:939-941.
13. Glaser JB, Dichter M. Staphylococcus aureus bacteremia in the elderly. Am J Med. 1990;88:554-555.
14. Helliwell M. Staphylococcus aureus infection complicating haemarthroses in elderly patients. Clin Rheumatol. 1985;4:90-92.
15. Hori S, Sunley R, Tami A, Grundmann H. The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital. J Hosp Infect. 2002;50:25-29.
16. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55:733-751.
17. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Susceptibility of aged mice to Staphylococcus aureus keratitis. Curr Eye Res. 2004;29:269-275.
18. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478-2482.
19. Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Curr Eye Res. 1997;16:1221-1228.
20. O'Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571-1578.
21. Walev I, Martin E, Jonas D, et al. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun. 1993;61:4972-4979.
22. Dajcs JJ, Thibodeaux BA, Girgis DO, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Biol. 2002;21:375-382.
23. Hume EB, Dajcs JJ, Moreau JM, O'Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun. 2000;68:6052-6055.
24. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 2005;46:2064-2070.
25. Emmerson AM, Garau J. Postoperative complications due to methicillin-resistant Staphylococcus aureus (MRSA) in an elderly patient: management and control of MRSA. J Hosp Infect. 1992;22(suppl A):43-50.
26. Inamatsu T, Ooshima H, Fukayama M, Masuda Y, Hatakeyama T. Methicillin resistant Staphylococcus aureus (MRSA) infection in geriatric hospital - management for infected decubital ulcer. Nippon Rinsho. 1992;50:1157-1162.
27. Washio M, Kiyohara C, Hamada T, Miyake Y, Arai Y, Okayama M. The case fatality rate of methicillin-resistant Staphylococcus aureus (MRSA) infection among the elderly in a geriatric hospital and their risk factors. Tohoku J Exp Med. 1997;183:75-82.
28. Asoh N, Masaki H, Watanabe H, et al. Molecular characterization of the transmission between the colonization of methicillin-resistant Staphylococcus aureus to human and environmental contamination in geriatric long-term care wards. Intern Med. 2005;44:41-45.
29. Booth MC, Pence LM, Mahasreshti P, Callegan MC, Gilmore MS. Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun. 2001;69:345-352.
30. Booth MC, Hatter KL, Miller D, et al. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun. 1998;66:356-360.
31. Oka S, Urayama K, Inamatsu T, Shimada K. Staphylococcal bacteremia, 2: review of 93 cases with Staphylococcus aureus bacteremia of the aged. Kansenshogaku Zasshi. 1986;60:602-607.
32. Washio M, Kiyohara C, Honjo N, et al. Methicillin-resistant Staphylococcus aureus (MRSA) isolation from pharyngeal swab cultures of Japanese elderly at admission to a geriatric hospital. J Epidemiol. 1997;7:167-172.
33. Washio M, Nishisaka S, Kishikawa K, et al. Incidence of methicillin-resistant Staphylococcus aureus (MRSA) isolation in a skilled nursing home: a third report on the risk factors for the occurrence of MRSA infection in the elderly. J Epidemiol. 1996;6:69-73.
34. Simor AE, Ofner-Agostini M, Paton S, et al. Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients. Infect Control Hosp Epidemiol. 2005;26:838-841.
35. Washio M, Fujishima M. Methicillin-resistant Staphylococcus aureus infection in the elderly. Nippon Ronen Igakkai Zasshi. 2000;37:759-762.
36. McClelland RS, Fowler VG Jr, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med. 1999;159:1244-1247.
37. Musch DC, Sugar A, Meyer RF. Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol. 1983;101:1545-1548.
38. Kunimoto DY, Sharma S, Garg P, Gopinathan U, Miller D, Rao GN. Corneal ulceration in the elderly in Hyderabad, South India. Br J Ophthalmol. 2000;84:54-59.
39. Washio M. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese elderly care nursing home. Epidemiol Infect. 1997;119:285.
40. Girgis DO, Reed JM, Monds KS, et al. Pathogenesis of Staphylococcus in the rabbit anterior chamber. Invest Ophthalmol Vis Sci. 2005;46:1371-1378.
41. Hume EB, Dajcs JJ, Moreau JM, Sloop GD, Willcox MD, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci. 2001;42:2904-2908.
42. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. A new topical model of Staphylococcus corneal infection in the mouse. Invest Ophthalmol Vis Sci. 2003;44:1591-1597.
43. Dajcs JJ, Austin MS, Sloop GD, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109-1115.
44. Dajcs JJ, Moreau JM, Thibodeaux BA, et al. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis. Cornea. 2001;20:878-880.
45. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993;12:461-467.
46. Hobden JA, Masinick SA, Barrett RP, Hazlett LD. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun. 1997;65:2754-2758.
47. Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1371-1378.
48. Hildebrand A, Pohl M, Bhakdi S. Staphylococcus aureus alpha-toxin: dual mechanism of binding to target cells. J Biol Chem. 1991;266:17195-17200.
49. Vijayvargia R, Suresh CG, Krishnasastry MV. Functional form of caveolin-1 is necessary for the assembly of α-hemolysin. Biochem Biophys Res Commun. 2004;324:1130-1136.
50. Vijayvargia R, Kaur S, Sangha N, et al. Assembly of α-hemolysin on A431 cells leads to clustering of caveolin-1. Biochem Biophys Res Commun. 2004;324:1124-1129.
51. Pany S, Vijayvargia R, Krishnasastry MV. Caveolin-1 binding motif of α-hemolysin: its role in stability and pore formation. Biochem Biophys Res Commun. 2004;322:29-36.
52. Fortin C, Larbi A, Lesur O, Douziech N, Fulop T. Impairmant of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to the age-related, altered functions. J Leukoc Biol. 2006;79:1061-1072.
53. Hobden JA, Masinick SA, Barrett RP, Hazlett LD. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1107-1114.
54. Hazlett L, Kreindler F, Berk R, Barrett R. Aging alters the phagocytic capability of inflammatory cells induced into the cornea. Curr Eye Res. 1990;9:129-138.
55. Kernacki K, Barrett R, McClellan S, Hazlett L. Aging and PMN response to P. aeruginosa infection. Invest Ophthalmol Vis Sci. 2000;41:3019-3025.